Effectiveness and durability of BNT162b2 vaccine against hospital and emergency department admissions due to SARS-CoV-2 omicron sub-lineages BA.1 and BA.2 in a large health system in the USA: a test-negative, case-control study

BACKGROUND: The SARS-CoV-2 omicron (B.1.1.529 BA.1) lineage was first detected in November, 2021, and is associated with reduced vaccine effectiveness. By March, 2022, BA.1 had been replaced by sub-lineage BA.2 in the USA. As new variants evolve, vaccine performance must be continually assessed. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Tartof, Sara Y, Slezak, Jeff M, Puzniak, Laura, Hong, Vennis, Frankland, Timothy B, Xie, Fagen, Ackerson, Bradley K, Valluri, Srinivas R, Jodar, Luis, McLaughlin, John M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9765328/
https://www.ncbi.nlm.nih.gov/pubmed/36216013
http://dx.doi.org/10.1016/S2213-2600(22)00354-X

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9765328/
https://www.ncbi.nlm.nih.gov/pubmed/36216013
http://dx.doi.org/10.1016/S2213-2600(22)00354-X

Ejemplares similares